{"id":"https://openalex.org/W58048110","doi":null,"title":"Assessment of TWIST1 as an immunotherapeutic target of cancer","display_name":"Assessment of TWIST1 as an immunotherapeutic target of cancer","publication_year":2011,"publication_date":"2011-10-28","ids":{"openalex":"https://openalex.org/W58048110","mag":"58048110"},"language":"en","primary_location":{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1333306","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1333306/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Doctoral thesis, UCL (University College London).","raw_type":"Thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012838760","display_name":"Edmund Poon","orcid":"https://orcid.org/0000-0002-7274-8718","observed_orcids":["https://orcid.org/0000-0002-7274-8718"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Edmund Poon","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7274-8718","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5012838760"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.05590000003576279,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.013700000010430813,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/twist1","display_name":"TWIST1","score":1.0},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.8330000042915344},{"id":"https://openalex.org/keywords/hla-a-0201","display_name":"HLA-A*0201","score":0.8790000081062317},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.7549999952316284},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.9670000076293945},{"id":"https://openalex.org/keywords/peptide-epitopes","display_name":"peptide epitopes","score":0.7419999837875366},{"id":"https://openalex.org/keywords/mhc-class-i-binding-prediction","display_name":"MHC class I binding prediction","score":0.6830000281333923},{"id":"https://openalex.org/keywords/bhlh-transcription-factors","display_name":"bHLH transcription factors","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.7287499904632568},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6812059283256531},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.6213432550430298},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5708135962486267},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5585609674453735},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5528261661529541},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5457146167755127},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.5453900098800659},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5218569040298462},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.521081805229187},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5196110606193542},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.49467942118644714},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.44735631346702576},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.4369063973426819},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41513362526893616},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3203383684158325},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1333306","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1333306/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Doctoral thesis, UCL (University College London).","raw_type":"Thesis"},{"id":"mag:58048110","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1333306/","pdf_url":null,"source":{"id":"https://openalex.org/S4306508231","display_name":"Doctoral thesis, UCL (University College London).","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Doctoral thesis, UCL (University College London).","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4280576480","https://openalex.org/W1993001612","https://openalex.org/W2072292305","https://openalex.org/W2559930465","https://openalex.org/W2094660101","https://openalex.org/W3178728592","https://openalex.org/W2094541817","https://openalex.org/W1964862727","https://openalex.org/W2529121688","https://openalex.org/W2554470717"],"abstract_inverted_index":{"CD8+":[0,238],"T":[1,152,239,291],"lymphocytes":[2],"are":[3],"key":[4],"mediators":[5],"of":[6,15,21,36,40,65,88,160,172,192,196,218,226,235,248,280,294,303,313],"anti-tumour":[7],"immunity,":[8],"eliminating":[9],"tumour":[10,16,23,30],"cells":[11,199,240,252],"through":[12],"the":[13,19,34,157,182,190,210,231,278,286,300,311],"recognition":[14,195],"antigens.":[17],"Increasing":[18],"number":[20,64],"characterised":[22],"antigens,":[24],"especially":[25],"those":[26],"with":[27,49,201,254],"highly":[28],"specific":[29,146,187],"expression,":[31],"may":[32],"enable":[33],"development":[35],"more":[37],"effective":[38],"immunotherapy":[39],"cancers.":[41],"TWIST1":[42],"is":[43,60,75],"a":[44,63,71],"basic-helix-loop-helix":[45],"transcription":[46],"factor":[47],"(bHLB)":[48],"an":[50,260],"important":[51],"role":[52],"in":[53,82,125,135,169,209,232],"cell":[54,271,292],"lineage":[55],"determination":[56],"and":[57,101,114,120,129,181,189,230,269,288,297,305],"differentiation.":[58],"It":[59],"expressed":[61,78],"by":[62,124,149,176,223],"carcinomas":[66],"where":[67],"it":[68],"functions":[69],"as":[70,118,307],"pro-metastatic":[72],"oncogene,":[73],"but":[74],"absent":[76],"or":[77],"at":[79],"low":[80],"levels":[81],"normal":[83],"tissues.":[84],"The":[85,137,216,273],"main":[86],"aim":[87],"this":[89],"study":[90],"was":[91,220],"to":[92,103,117,132,144],"investigate":[93],"whether":[94],"anti-TWIST1":[95,282],"immune":[96,147],"responses":[97,148],"could":[98],"be":[99],"generated":[100,185],"used":[102],"target":[104,198,308],"cancer":[105],"cells.":[106],"\\nTwo":[107],"potential":[108],"HLA-A0201":[109],"restricted":[110],"TWIST1-derived":[111],"epitopes,":[112],"SLNEAFAAL":[113],"KLAARYIDFL":[115],"(referred":[116],"SLN":[119,164,304],"KLA)":[121],"were":[122,139,167,206,257],"identified":[123],"silico":[126],"prediction":[127],"methods":[128],"their":[130,142],"binding":[131],"HLA-A*0201":[133,227],"confirmed":[134],"vitro.":[136],"peptides":[138],"assessed":[140,222],"for":[141,310],"capacity":[143],"induce":[145],"generating":[150],"cytotoxic":[151],"lymphocyte":[153],"(CTL)":[154],"lines":[155],"from":[156,241,259],"peripheral":[158],"blood":[159,244],"HLA-A2-positive":[161,213],"healthy":[162,174,212,243,295],"donors.":[163,245],"peptide-specific":[165,204,237],"CTLs":[166,205,246],"detected":[168,208],"1":[170],"out":[171],"5":[173],"donors":[175,214],"peptide/MHC":[177],"class":[178],"I":[179],"pentamers":[180],"CTL":[183,262,283],"line":[184,264],"showed":[186],"cytotoxicity":[188],"release":[191],"interferon-\u03b3":[193],"on":[194],"T2":[197,251],"pulsed":[200,253],"SLN.":[202],"KLA":[203,219,255,306],"not":[207],"four":[211],"tested.":[215],"immunogenicity":[217],"also":[221],"peptide":[224,256],"immunisation":[225],"transgenic":[228],"mice":[229],"vitro":[233],"stimulation":[234],"alloreactive":[236,261],"HLA-A2-negative":[242],"capable":[247],"specifically":[249],"killing":[250],"isolated":[258],"bulk":[263],"using":[265],"peptide/HLA-A*0201":[266],"pentamer":[267],"reagents":[268],"magnetic":[270],"sorting.":[272],"data":[274],"presented":[275],"here":[276],"shows":[277],"existence":[279],"functional":[281],"precursors":[284],"within":[285],"autologous":[287],"allogeneic":[289],"HLA-A*0201-restricted":[290],"repertoires":[293],"donors,":[296],"therefore":[298],"merits":[299],"further":[301],"evaluation":[302],"epitopes":[309],"treatment":[312],"TWIST1+":[314],"tumours.":[315]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}